Cargando…

No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19. Data of 397 adult patients with severe COVID-19 admitted to a designated clinical center of Wuhan Union...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Shaoping, Chen, Qiaosen, Jiang, Hongbo, Guo, Chunxia, Luo, Jinzhuo, Li, Sumeng, Wang, Hua, Li, Huadong, Zheng, Xin, Weng, Zhihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459914/ https://www.ncbi.nlm.nih.gov/pubmed/34616916 http://dx.doi.org/10.1515/med-2021-0361

Ejemplares similares

Association of Complement C3 with Clinical Deterioration Among Hospitalized Patients with COVID-19
por: Jiang, Hongbo, et al.
Publicado: (2022)

ANDC: an early warning score to predict mortality risk for patients with Coronavirus Disease 2019
por: Weng, Zhihong, et al.
Publicado: (2020)

Single-cell transcriptomic analysis reveals a novel cell state and switching genes during hepatic stellate cell activation in vitro
por: Wang, Hua, et al.
Publicado: (2022)

Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization
por: Zheng, Shaoping, et al.
Publicado: (2016)

Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance
por: Zheng, Di, et al.
Publicado: (2022)

Aclidinium Bromide: Clinical Benefit in Patients with Moderate to Severe COPD
por: Suppli Ulrik, Charlotte
Publicado: (2012)

Liver Function Derangement in Patients with Severe Fever and Thrombocytopenia Syndrome
por: Lu, Sihong, et al.
Publicado: (2022)

Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia
por: Zhao, Bing, et al.
Publicado: (2022)

Evaluation of Mycophenolate Mofetil and Low-Dose Steroid Combined Therapy in Moderately Severe Henoch-Schönlein Purpura Nephritis
por: Lu, Zhihong, et al.
Publicado: (2017)

Letter regarding “The clinical efficacy of low-dose whole-lung irradiation in moderate-to-severe COVID-19 pneumonia: RTMX-20 trial”
por: Li, Zheng, et al.
Publicado: (2023)

Association between vitamin C intake and lung cancer: a dose-response meta-analysis
por: Luo, Jie, et al.
Publicado: (2014)

High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
por: Xia, Guozhi, et al.
Publicado: (2021)

Inhibition of Notch Signaling by a γ-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats
por: Chen, Yixiong, et al.
Publicado: (2012)

Multimethod quantitative benefit‐risk assessment of treatments for moderate‐to‐severe osteoarthritis
por: Mauer, Jonathan, et al.
Publicado: (2022)

The Impact of Moderate-Dose Acetylsalicylic Acid in the Reduction of Inflammatory Cytokine and Prevention of Complication in Acute Phase of Kawasaki Disease: The Benefit of Moderate-Dose Acetylsalicylic Acid
por: Kwon, Jung Eun, et al.
Publicado: (2020)

Effect of high-dose intravenous vitamin C therapy on the prognosis in patients with moderately severe and severe acute pancreatitis: protocol of a prospective, randomized, double-blinded, placebo-controlled study
por: Sun, Wenwu, et al.
Publicado: (2023)

Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy
por: Lin, Miaoli, et al.
Publicado: (2015)

Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection
por: Douin, Clara, et al.
Publicado: (2022)

Benefits of Vitamins in the Treatment of Parkinson's Disease
por: Zhao, Xiuzhen, et al.
Publicado: (2019)

Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)
por: Honma, Masaru, et al.
Publicado: (2020)

Vitamin D, vitamin D receptor and tissue barriers
por: Zhang, Yong-guo, et al.
Publicado: (2013)

Persistent or new symptoms 1 year after a single high dose of vitamin D(3) in patients with moderate to severe COVID-19
por: Fernandes, Alan L., et al.
Publicado: (2022)

Evidence for the Efficacy of a High Dose of Vitamin D on the Hyperinflammation State in Moderate-to-Severe COVID-19 Patients: A Randomized Clinical Trial
por: Sarhan, Neven, et al.
Publicado: (2022)

Vitamin D and Stroke: Effects on Incidence, Severity, and Outcome and the Potential Benefits of Supplementation
por: Yarlagadda, Keerthi, et al.
Publicado: (2020)

Vitamin D and COVID-19 Severity in Hospitalized Older Patients: Potential Benefit of Prehospital Vitamin D Supplementation
por: Parant, François, et al.
Publicado: (2022)

Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C
por: Vollbracht, Claudia, et al.
Publicado: (2022)

Gradually increasing the dosing interval of Secukinumab for moderate to severe plaque psoriasis: A single‐center, uncontrolled, prospective study in 36 weeks
por: Chen, Xi‐Bei, et al.
Publicado: (2022)

Prognostic significance of sarcopenia and severe vitamin D deficiency in patients with cirrhosis
por: Saeki, Chisato, et al.
Publicado: (2023)

Clinical significance of Vitamin-D and other bone turnover markers on bone mineral density in patients with gestational diabetes mellitus
por: Ma, Jingjing, et al.
Publicado: (2022)

Long-Dose Intensive Therapy Is Necessary for Strong, Clinically Significant, Upper Limb Functional Gains and Retained Gains in Severe/Moderate Chronic Stroke
por: Daly, Janis J., et al.
Publicado: (2019)

The health benefits of vitamin K
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain
por: Pergolizzi, Joseph V, et al.
Publicado: (2012)

The Significance of Transcapsular Blood Flow for Assessing Moderate to Severe Extrathyroidal Extension: Results of a Two-Center Study
por: Li, Zhi, et al.
Publicado: (2022)

Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
por: Karonova, Tatiana L., et al.
Publicado: (2022)

Progesterone Treatment Shows Benefit in a Pediatric Model of Moderate to Severe Bilateral Brain Injury
por: Geddes, Rastafa I., et al.
Publicado: (2014)

Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
por: Conaghan, Philip, et al.
Publicado: (2021)

Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis
por: Ebadi, Maryam, et al.
Publicado: (2023)

Classification and clinical significance of the posterior group of renal calyces
por: Qi, Yucheng, et al.
Publicado: (2023)

Comparing the Efficacy of Low Dose and Conventional Dose of Oral Isotretinoin in Treatment of Moderate and Severe Acne Vulgaris
por: Faghihi, Gita, et al.
Publicado: (2017)

Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
por: Xu, Xinghua, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kv6q8n2h7la4lbe7vt4h3fvkaj